Non-small-cell lung cancer (NSCLC) is the most prevalent histological cancer subtype worldwide 1 . As the majority of patients present with invasive, metastatic disease 2 , it is vital to understand the basis for lung cancer progression. Hmga2 is highly expressed in metastatic lung adenocarcinoma, in which it contributes to cancer progression and metastasis 3-6 . Here we show that Hmga2 promotes lung cancer progression in mouse and human cells by operating as a competing endogenous RNA (ceRNA) 7-11 for the let-7 microRNA (miRNA) family. Hmga2 can promote the transformation of lung cancer cells independent of protein-coding function but dependent upon the presence of let-7 sites; this occurs without changes in the levels of let-7 isoforms, suggesting that Hmga2 affects let-7 activity by altering miRNA targeting. These effects are also observed in vivo, where Hmga2 ceRNA activity drives lung cancer growth, invasion and dissemination. Integrated analysis of miRNA target prediction algorithms and metastatic lung cancer gene expression data reveals the TGF-b co-receptor Tgfbr3 (ref. 12) as a putative target of Hmga2 ceRNA function. Tgfbr3 expression is regulated by the Hmga2 ceRNA through differential recruitment to Argonaute 2 (Ago2), and TGF-b signalling driven by Tgfbr3 is important for Hmga2 to promote lung cancer progression. Finally, analysis of NSCLC-patient geneexpression data reveals that HMGA2 and TGFBR3 are coordinately regulated in NSCLC-patient material, a vital corollary to ceRNA function. Taken together, these results suggest that Hmga2 promotes lung carcinogenesis both as a protein-coding gene and as a non-coding RNA; such dual-function regulation of gene-expression networks reflects a novel means by which oncogenes promote disease progression.
Non-small-cell lung cancer (NSCLC) is the most prevalent histological cancer subtype worldwide 1 . As the majority of patients present with invasive, metastatic disease 2 , it is vital to understand the basis for lung cancer progression. Hmga2 is highly expressed in metastatic lung adenocarcinoma, in which it contributes to cancer progression and metastasis [3] [4] [5] [6] . Here we show that Hmga2 promotes lung cancer progression in mouse and human cells by operating as a competing endogenous RNA (ceRNA) [7] [8] [9] [10] [11] for the let-7 microRNA (miRNA) family. Hmga2 can promote the transformation of lung cancer cells independent of protein-coding function but dependent upon the presence of let-7 sites; this occurs without changes in the levels of let-7 isoforms, suggesting that Hmga2 affects let-7 activity by altering miRNA targeting. These effects are also observed in vivo, where Hmga2 ceRNA activity drives lung cancer growth, invasion and dissemination. Integrated analysis of miRNA target prediction algorithms and metastatic lung cancer gene expression data reveals the TGF-b co-receptor Tgfbr3 (ref. 12 ) as a putative target of Hmga2 ceRNA function. Tgfbr3 expression is regulated by the Hmga2 ceRNA through differential recruitment to Argonaute 2 (Ago2), and TGF-b signalling driven by Tgfbr3 is important for Hmga2 to promote lung cancer progression. Finally, analysis of NSCLC-patient geneexpression data reveals that HMGA2 and TGFBR3 are coordinately regulated in NSCLC-patient material, a vital corollary to ceRNA function. Taken together, these results suggest that Hmga2 promotes lung carcinogenesis both as a protein-coding gene and as a non-coding RNA; such dual-function regulation of gene-expression networks reflects a novel means by which oncogenes promote disease progression.
The ceRNA hypothesis posits that specific RNAs can function as sinks for pools of active miRNAs, functionally liberating other transcripts targeted by that set of miRNAs 10 . Downregulation of the transcription factor Nkx2.1 promotes lung adenocarcinoma progression partially through derepression of Hmga2 (ref. 6 ), a non-histone chromosomal high-mobility group protein. Intriguingly, Hmga2 has been described as a prototypic let-7 target transcript, with seven conserved sites in its 39 untranslated region (39 UTR) 13 . Reduction of Hmga2 by RNA interference, which would deplete both Hmga2 protein and transcript, greatly reduces metastatic ability. Thus, it is possible that the transcript could operate independently of the protein in lung cancer progression.
To determine whether Hmga2 can operate as a ceRNA for the let-7 family, we generated an allelic series of Hmga2 expression constructs (Fig. 1a ). In this series, we expressed the wild-type full-length Hmga2 complementary DNA (WT); Hmga2 with mutation of all seven predicted let-7 binding sites 13 (m7); Hmga2 with mutation of the single inframe start codon (ATG WT); or Hmga2 with mutation of both the start codon and the let-7 binding sites (ATG m7). We then examined these constructs in two lung cancer cell lines generated from the Kras LSL-G12D ;Trp53 flox/flox mouse model: a cell line derived from a non-metastatic lung tumour that expresses very low levels of Hmga2 (368T1); and a cell line derived from a lymph node metastasis which expresses high levels of Hmga2 (482N1) 6 . Using two antibodies that recognize either the amino-terminus or the second AT-hook of the protein (M. Narita, personal communication), we found that the Hmga2 WT and m7 constructs efficiently express full-length Hmga2 protein (m7 overexpresses Hmga2 owing to loss of let-7-mediated suppression), whereas the Hmga2 ATG WT and ATG m7 constructs do not ( Fig. 1b) . Importantly, we observed similar levels of Hmga2 transcript expressed in the allelic series (in the case of the 482N1 cell line, the allelic series was mutated to abrogate binding to a short hairpin RNA (shRNA) against Hmga2) ( Fig. 1c) . Moreover, expression of the allelic series has no effect on the expression of various let-7 family members (Extended Data Fig. 1a ). Taken together, this Hmga2 allelic series allows us to compare specifically the roles of Hmga2 protein and transcript function on lung cell transformation.
We therefore compared the ability of the Hmga2 allelic series to promote anchorage-independent growth of the lung cancer cell lines. We observed a striking promotion of soft-agar growth by both Hmga2 WT and ATG WT in the 368T1 and 482N1 cells (Figs. 1d, e); more modest growth was observed with Hmga2 m7, despite elevated protein expression relative to Hmga2 WT, and no growth was provided by Hmga2 ATG m7. This effect can be observed further in two additional human lung cancer cells (H1299 and SK-MES-1), as suppression of soft-agar growth by HMGA2 depletion can be rescued robustly by Hmga2 WT and ATG WT but more modestly by Hmga2 m7 (Extended Data Fig. 1b-e ). Importantly, exogenous expression of let-7 reversed the ability of the Hmga2 ceRNA to promote anchorage-independent growth, suggesting that let-7 regulates this effect (Extended Data Fig. 2b ). To demonstrate that the effect of the Hmga2 ceRNA is driven by let-7 sites in the 39 UTR, we expressed only the wild-type or let-7site-mutated 39 UTRs in 368T1 cells and examined the consequences on anchorage-independent growth. Notably, expression of the wildtype but not let-7-mutant 39 UTR was sufficient to promote soft-agar growth in 368T1 cells (Extended Data Fig. 2c ).
Beyond direct Hmga2 depletion, the Hmga2 WT and Hmga2 ATG WT constructs substantially rescued anchorage-independent growth in 482N1 cells stably overexpressing Nkx2.1, which we have previously shown to suppress lung cancer progression 6 (Extended Data Fig. 2d ). Notably, this effect is not due to a general proliferative benefit of Hmga2 WT and ATG WT cells, as BrdU (bromodeoxyuridine; 5-bromo-29deoxyuridine) incorporation in adherent conditions was comparable across the allelic series (Extended Data Fig. 3a ). However, when lung cancer cells are placed in suspension, Hmga2 depletion suppressed proliferation and this proliferation was rescued substantially by Hmga2 WT and ATG WT, and more marginally by Hmga2 m7 (Extended Data Fig. 3b ); in contrast, the rate of apoptosis in the allelic series was not affected by growth in suspension (data not shown). Taken together, these results suggest that the Hmga2 transcript functions in a largely protein-coding-independent but let-7-site-dependent manner to promote lung cancer cell transformation in vitro.
To examine the effect of Hmga2 ceRNA activity on lung cancer cell dissemination in vivo, we intravenously transplanted 482N1 cells expressing either the control shRNA and expression construct or the shRNA targeting Hmga2 plus the Hmga2 allelic series into syngeneic mice. As seen in Fig. 2a , micro-computed tomography (micro-CT) analysis revealed a substantial rescue of lung tumour formation with expression of either the Hmga2 WT or ATG WT constructs (with more modest effects with the Hmga2 m7 construct). Histopathological analysis and quantification of surface lesions confirmed the effects of Hmga2 ceRNA activity on in vivo lung tumorigenesis (Figs. 2b, c) . Moreover, the control shRNA, the shHmga2 plus Hmga2 WT and the shHmga2 plus Hmga2 ATG WT transplants generate a highly metastatic disease, with lesions disseminating to both local and distant lymph nodes, kidney, and the abdominal and thoracic cavities (data not shown). We also examined the effect of Hmga2 ceRNA function on survival in the transplant system. We observed a dramatic reduction in survival in animals transplanted with the Hmga2 WT and ATG WT cells, similar to that seen with transplant of the control shRNA cells (Fig. 2d ); we noted a more modest reduction in survival with transplant of the Hmga2 m7 cells. In total, these findings indicate that Hmga2 competing RNA activity dramatically promotes in vivo lung cancer formation.
To elucidate the mechanism of Hmga2 ceRNA function on lung carcinogenesis, we analysed the set of genes differentially expressed between metastatic and non-metastatic Kras G12D ;Trp53 2/2 lung cancer cells 6 and compared them to the list of predicted let-7 target genes based upon the miRNA target prediction algorithm TargetScan 14 (Supplementary Table 5 ). Kras was not a candidate in this analysis, in spite of previous description of Kras as an important let-7 target 15 . Moreover, the Hmga2 allelic series had no impact on either expression of K-Ras protein or activity of downstream K-Ras signalling pathways (Extended Data Fig. 3c ). In contrast, we observed several known Hmga2 transcriptional targets, including components of the Igf2bp family 16 , validating this approach.
To elucidate more broadly which transcripts are Hmga2 ceRNA targets, we initially examined whether let-7 sites are enriched among transcripts induced by the Hmga2 ceRNA through RNA-seq of the 482N1 allelic series combined with Sylamer analysis, which detects miRNA seed sites as nucleotide strings enriched within the 39 UTRs of transcripts 17 . We first compared control to Hmga2-knockdown cells and observed a specific enrichment of let-7 sites lost with Hmga2 depletion (Extended Data Fig. 4a ). We then determined whether this was specific to ceRNA activity by determining let-7-site enrichment upon re-expression of either the Hmga2 WT or ATG WT constructs in Hmga2-knockdown cells. In both conditions, let-7 sites were enriched among the upregulated transcripts (Extended Data Fig. 4b , c) Importantly, let-7 sites were not enriched with re-expression of either Hmga2 m7 or ATG m7 in the Hmga2-depleted background (Extended Data Fig. 4d, e ). Moreover, analysis of fragments per kilobase of exon per million fragments mapped (FPKM) in the RNA sequencing (RNAseq) results from control 482N1 cells showed Hmga2 was among the most highly expressed predicted let-7 target transcripts, suggesting that Hmga2 constitutes a physiologically germane fraction of the let-7 target milieu (Supplementary Table 6 ). Taken together, these results indicate that the Hmga2 ceRNA broadly regulates let-7 targets.
To assess Hmga2 ceRNA targets more specifically, we examined which transcripts were suppressed in response to Hmga2 depletion; 13 out of 34 predicted targets were suppressed by Hmga2 knockdown (Extended Data Fig. 5a ). To delineate which of these were Hmga2 transcriptional targets versus ceRNA targets, we re-expressed either Hmga2 WT or ATG WT in knockdown cells. As seen in Extended Data Fig. 5b , 6 out of 13 transcripts were rescued by both Hmga2 WT and ATG WT, suggesting they are putative ceRNA targets; the remaining targets were rescued only by Hmga2 WT, suggesting they are targets of Hmga2 transcription factor function. These Hmga2 ceRNA targets were markedly enriched in let-7-regulated transcripts, as their repression by Hmga2 loss could be reversed with the use of a 'tough decoy' let-7 sponge transcript, designed to be an efficient and long-term the cDNA with all seven let-7 sites in the 39 UTR mutated ('m7'); the cDNA with the start codon mutated ('ATG WT'); and the cDNA with both the start codon and let-7 sites mutated ('ATG m7'). ORF, open reading frame. Xs represent mutations of the let-7 sites in the Hmga2 39 UTR. b, Hmga2 WT and m7 induce Hmga2 expression in non-metastatic lung cancer cells (368T1) and restore expression in metastatic lung cancer cells (482N1) depleted for endogenous Hmga2 (shHmga2). Two distinct HMGA2 antibodies are used: one recognizes the N-terminus of HMGA2 (HMGA2-CST) and the other recognizes the central AT-hook region of HMGA2 (HMGA2-Narita). c, Hmga2 RNA is comparably expressed by the WT, m7, ATG WT, and ATG m7 constructs in both 368T1 and 482N1 cells. Hmga2 expression is normalized to Gapdh. 368T1 values are normalized to empty and 482N1 values are normalized to shluc empty (which express a shRNA targeting luciferase and the empty expression vector). Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. d, Hmga2 WT and ATG WT promote substantial anchorage-independent growth in both 368T1 and 482N1 cells. Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. e, Representative images of soft agar colonies. Magnification is 310. ***P , 0.0005; **P , 0.005; *P , 0.05.
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suppressor of miRNA function (Extended Data Fig. 5c ) 18 . Conversely, overexpression of let-7 suppressed these transcripts, although Hmga2 transcriptional targets were also affected owing to depletion of Hmga2 (Extended Data Fig. 5d ). Taken together, these studies outline a collection of putative target transcripts regulated by Hmga2 ceRNA function. Among these six Hmga2 ceRNA target transcripts, we found the TGF-b co-receptor Tgfbr3 (ref. 12) to be both upregulated in metastatic lung cancer cells and a putative let-7 target. Furthermore, several Hmga2 ceRNA targets have been described as targets of TGF-b signalling 19 . Thus, we examined whether Hmga2 exerts ceRNA function through enhanced TGF-b signalling via Tgfbr3. Consistent with this, we found that in both 368T1 and 482N1 cells, Hmga2 WT and ATG WT promote the expression of Tgfbr3 protein (Fig. 3a ). This Tgfbr3 upregulation also occurs to a lesser degree at the messenger RNA level, as has been described previously for miRNA targets 20 (Fig. 3b ). Moreover, exogenous expression of let-7 reversed the ability of the Hmga2 ceRNA to upregulate Tgfbr3, suggesting that this effect is controlled by let-7 (Extended Data Fig. 2a ). An important consideration in ceRNA-target analysis is the absolute levels of Hmga2, Tgfbr3 and let-7 transcripts in cells, so we determined the copies per cell of these factors (Extended Data Fig. 4f ). We observed that Hmga2 and Tgfbr3 had similar levels of transcript, as might be expected for two factors that can titrate expression of one another; similar results were observed in FPKM analysis of these transcripts in control 482N1 cells by RNA-seq (Supplementary Table 6 ). Furthermore, total let-7 family expression was within an order of magnitude of Hmga2 and Tgfbr3. As this pool of let-7 regulates the entire target set, it is possible that miRNA occupancy to be a limiting factor, allowing for the contribution of a ceRNA-like Hmga2. Taken together, these results suggest that Hmga2 may regulate Tgfbr3 expression as a let-7 ceRNA.
In line with these observations of Hmga2 promoting Tgfbr3 expression, Hmga2 WT and ATG WT activated TGF-b signalling through phosphorylation of Smad2 (Fig. 3a ). This effect was let-7-dependent, as exogenous let-7 suppressed Smad2 phosphorylation (Extended Data Fig. 2a ). It is likely that the TGF-b pathway is active in the absence of exogenous ligand owing to low but detectable levels of TGF-b in serum during cell culture 21 . We further examined whether Hmga2 ceRNA function affects TGF-b pathway activation by two methods. First, we found that a TGF-b reporter (CAGA12) 22 was potently induced by Hmga2 WT and ATG WT (Extended Data Fig. 5e ). Second, analysis of TGF-b target transcript levels revealed specific expression of these genes with the Hmga2 WT and ATG WT constructs (Extended Data Fig. 5f ). Notably, we observed little activation of the TGF-b pathway by Hmga2 m7, despite previous reports of Hmga2 functioning as a coactivator for Smad2, Smad3 and Smad4 in the epithelial-mesenchymal transition (EMT) 23 ; this is likely to be due to the lack of upstream activation of the pathway. Consistent with this, the Hmga2 ceRNA does not induce an EMT in either 368T1 or 482N1 cells (Extended Data Fig. 6a ). Overall, these results indicate that the Hmga2 ceRNA induces expression of Tgfbr3 and potentiates TGF-b signalling.
To determine whether the effects of Hmga2 on Tgfbr3 occur through let-7-mediated derepression, we first examined the effect of Hmga2 ceRNA function on a reporter containing the Tgfbr3 39 UTR. In both 368T1 and 482N1 cells, Hmga2 WT and ATG WT induced expression of luciferase under the control of the wild-type Tgfbr3 39 UTR, but not if the let-7 site was mutated ( Fig. 3c ). Furthermore, we found that the effect of the Hmga2 ceRNA was broadly miRNA-dependent, as Hmga2 WT and ATG WT induced the reporter expression in Dicer1intact sarcoma cells, but not in a Dicer1-null derivative cell line 24 (Extended Data Fig. 6b ). To assess directly whether Hmga2 induces Tgfbr3 through competition away from Ago2, we performed RNA immunoprecipitation (RIP) on Ago2 in lung cancer cells expressing the Hmga2 allelic series. As shown in Fig. 3d , we found that Hmga2 WT and ATG WT were recruited to Ago2 at levels comparable to the a, Hmga2 WT and ATG WT restore lung tumour growth in response to endogenous Hmga2 knockdown. B6129SF1/Tac males were intravenously injected with 482N1 cells expressing either a control shRNA and empty vector (shluc empty) or shHmga2 with the Hmga2 allelic series. Three weeks afterwards, animals were scanned by micro-CT and representative transverse images are shown. The heart is demarcated ('H') and white arrows identify lung tumours. b, Representative histological images of lungs transplanted with 482N1 cells from the series described in a. Magnification is 31. c, Lung surface tumour counts were taken from animals transplanted with 482N1 cells from the series described in a (n 5 3 animals per group). Values are technical triplicates and represent mean 6 s.e.m. d, Hmga2 WT and ATG WT substantially reduce survival of animals transplanted with 482N1 cells expressing the shRNA targeting Hmga2. Animals were intravenously transplanted with cells as in a. Animals were subsequently aged for survival and a Kaplan-Meier analysis was performed (n 5 9 animals per group). Median survival was 34 days for shluc empty and shHmga2 WT transplants; 37 days for shHmga2 ATG WT transplants; 43 days for shHmga2 m7 transplants; and 50 days for shHmga2 empty and ATG m7 transplants. Statistical significance was assessed by log-rank tests compared to shHmga2 empty. ****P ,0.00005; ***P , 0.0005; **P , 0.005; *P , 0.05; NS, not significant.
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Macmillan Publishers Limited. All rights reserved ©2014 recruitment of endogenous Hmga2, whereas Hmga2 m7 and ATG m7 were not. Moreover, Hmga2 WT and ATG WT cells had a substantial decrease in Tgfbr3 recruitment to Ago2. Of note, these effects on Ago2 occupancy by Tgfbr3 are not caused by a change in let-7 activity, as various let-7 family members were comparably loaded on Ago2 across the Hmga2 allelic series (Extended Data Fig. 7 ). Thus, these results demonstrate Hmga2, through its let-7-binding sites, displaces Tgfbr3 from miRNA-mediated repression by Ago2. In total, these results suggest that the Hmga2 ceRNA directly functions by blocking recruitment of Tgfbr3 to the Ago2-based miRNA repression complex.
To examine whether Hmga2 ceRNA activity through Tgfbr3 is functionally relevant, we used shRNAs to deplete Tgfbr3 in 482N1 cells and 368T1 cells expressing either Hmga2 WT or ATG WT. At both the mRNA and protein level, multiple shRNAs reduced Tgfbr3 expression (Figs. 3e, f). Moreover, knockdown of Tgfbr3 led to substantial suppression of TGF-b signalling, as evidenced by loss of Smad2 
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phosphorylation, CAGA12 reporter activity and expression of TGF-b target genes ( Fig. 3f and Extended Data Fig. 8a, b ). We then assessed the functional effect of Tgfbr3 loss on Hmga2 ceRNA-driven soft-agar colony formation. In all cells, Tgfbr3 knockdown notably suppressed anchorage-independent growth, but not to the same extent as Hmga2 depletion in 482N1 cells (Fig. 3g ). This occurred without generally affecting proliferation, as measured by BrdU incorporation (Extended Data Fig. 8c ). We further functionally analysed the broader set of six Hmga2 ceRNA targets by individually depleting them by short interfering RNA (siRNA) (Extended Data Fig. 8d ). When we compared their effects on anchorage-independent growth, both Hmga2 and Tgfbr3 loss strongly suppressed growth, Hmga1 depletion modestly reduced colony formation, whereas the remaining targets had little effect (Extended Data Fig. 8e ). It should be noted that these other targets include extracellular factors like Angptl2 and Col1a2 that might promote lung cancer progression in vivo in a non-cell-autonomous manner, and could thus still be relevant to Hmga2 ceRNA activity in lung cancer progression. This considered, these results still indicate that Tgfbr3, although certainly not the only relevant Hmga2 ceRNA target, is an important effector of Hmga2 ceRNA function in lung cancer cell transformation.
To determine whether this effect of Tgfbr3 is driven through potentiation of TGF-b signalling, we inhibited the TGF-b pathway with the TGF-b-receptor-kinase inhibitor SB-431542 (SB) 25 . In 368T1 and 482N1 cells, SB treatment led to a substantial inhibition of Smad2 phosphorylation (Extended Data Fig. 9a ). In addition, SB treatment of 482N1 and 368T1 Hmga2 WT and ATG WT cells markedly suppressed CAGA12 reporter activity and expression of TGF-b target genes (Extended Data Fig. 9b, c) . We then examined whether SB could inhibit Hmga2 ceRNA-driven soft-agar colony formation and observed a striking reduction in anchorage-independent growth (Extended Data Fig. 9d ). This impaired colony formation was not due to general proliferative arrest, as SB treated cells had a similar rate of BrdU incorporation (Extended Data Fig. 9e ). Notably, many Hmga2 ceRNA targets are in fact TGF-b target genes, as their expression is suppressed by SB treatment and induced by exogenous addition of TGF-b (Extended Data Fig. 9f, g) . Thus, it is possible that Hmga2 could function in a feedforward loop in which it regulates TGF-b target genes directly through ceRNA function and indirectly through TGF-b signalling via Tgfbr3. In summary, these results indicate that TGF-b signalling through Tgfbr3 is an important pathway downstream of Hmga2 ceRNA function.
Based on the above findings, we wanted to examine whether HMGA2 functions as a ceRNA for TGFBR3 (the human orthologues of Hmga2 and Tgfbr3, respectively) in NSCLC patients. An important corollary of the ceRNA hypothesis is the coordinate regulation of a competing RNA and its targets, such that upregulation of the ceRNA should lead to higher expression of the target RNA and vice versa 10 . To assess this, we used NSCLC gene-expression data generated by the Cancer Genome Atlas (TCGA) and sorted the patient cohort into the top and bottom quartiles of HMGA2 expression (HMGA2 high and low, respectively) ( Fig. 4a ). As seen in Fig. 4b , we observed significantly higher levels of TGFBR3 transcript in HMGA2 high versus low patient samples. To address the converse relationship, we sorted the TCGA data set into top and bottom quartiles of TGFBR3 expression (TGFBR3 high and low, respectively) ( Fig. 4c ). When we compared HMGA2 transcript levels between the groups, we found HMGA2 to be significantly overexpressed in TGFBR3 high versus low patient samples ( Fig. 4d) . To extend and validate these findings, we carried out similar gene-expression analyses of HMGA2 and TGFBR3 in an independent lung-adenocarcinomapatient gene-expression cohort, the Director's Challenge data set 26 . Similar to the findings with the TCGA cohort, we observed HMGA2 and TGFBR3 to be coordinately expressed in the Director's Challenge data set (Extended Data Fig. 10a-d) . Although we focused specifically on high and low expressors of HMGA2 and TGFBR3, for which ceRNA activity is more likely to occur 10 , HMGA2 and TGBR3 expression was broadly correlated across both data sets (Extended Data Fig. 10e, f ). As these two data sets constitute two of the largest collections of NSCLC gene-expression data available, we believe that these findings are consistent with HMGA2 functioning as a ceRNA for TGFBR3 in NSCLC patients. It is possible that the coexpression of HMGA2 and TGFBR3 could correspond to additional tumour characteristics that these data sets do not include; future studies in independent data sets would be needed to assess this issue. In total, our results suggest a model in which Hmga2 promotes lung cancer progression by competing for let-7 occupancy with other targets, including Tgfbr3, leading to the upregulation of those targets (Fig. 4e ). Importantly, this occurs without changes in the levels of let-7 family microRNAs, reflecting specific competition for microRNA binding among targets.
Here we have outlined a novel gene-expression pathway in which a protein-coding gene, Hmga2, operates largely independently of its protein-coding function to promote lung cancer progression as a competing endogenous RNA. Although much of this ceRNA activity is Significance was assessed by the Mann-Whitney test with a Bonferroni correction for multiple hypothesis testing. ***P , 0.0005. e, Model for Hmga2 acting as a competing endogenous RNA for Tgfbr3. In non-metastatic NSCLC, Hmga2 expression is low, leading to suppressed Tgfbr3 expression by let-7. In metastatic NSCLC, Hmga2 expression is elevated, titrating away let-7 from Tgfbr3 and allowing for its overexpression. This titration occurs without changes in let-7 expression, reflecting competition for microRNA occupancy by target transcripts.
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driven by overexpression of TGF-b signalling through Tgfbr3, there are likely to be additional Hmga2 ceRNA targets to be found in future studies. Moreover, HMGA2 is overexpressed in many other cancer types 27 , so it is possible that HMGA2 functions as a ceRNA in cancer sites beyond lung. Taken more broadly, these findings raise the possibility that many protein-coding genes differentially expressed in cancer might contribute to tumorigenesis through this distinct mode of regulatory gene expression. Moreover, these results raise issues with the validation of candidates in RNA interference screens. The 'gold standard' assay for validating an siRNA target is expression of an siRNA-resistant form of the coding sequence 28 ; however, such an approach overlooks the possibility that depletion of both the fulllength RNA and protein might contribute to a given phenotype, requiring complementation by the full-length transcript. Such dualfunction ceRNA and protein activities necessitate a deeper exploration of the coding genome in biological systems.
METHODS SUMMARY
Soft-agar assays. Soft-agar assays were performed essentially as described previously 6 . Assays were carried out in triplicate and quantified by microscope. Intravenous transplantation. Intravenous injection was performed on 12-weekold B6129SF1/Tac male mice (Taconic), essentially as described previously 6 . In short, 10 5 cells in 50 ml PBS were injected into 12 animals per group. Three weeks post injection, animals were scanned using the SkyScan 1176 micro-CT scanner as described previously 29 . Three mice per group were then euthanized at random for surface tumour and histopathological analysis. Surface tumours were quantified by counting all the visible tumours on the lung pleura; quantification was carried out blind to the expression construct. The remaining nine mice were aged for survival analysis. All procedures were performed under an approved project license as per UK Home Office regulations. RNA immunoprecipitation. RNA immunoprecipitation was carried out on 482N1 and 368T1 cells with control antibodies (immunoglobulin G (IgG)) or antibody targeting Ago2 as per manufacturers' instructions (Millipore). Total RNA was used for either qRT-PCR (quantitative polymerase chain reaction with reverse transcription) of mRNAs or miRNA-specific qRT-PCR as above.
Public gene-expression array analysis. NSCLC gene-expression data sets (from both The Cancer Genome Atlas (TCGA) and the Director's Challenge 26 ) were downloaded and processed using standard methods. Patient expression profiles were sorted by HMGA2-or TGFBR3-expression status, and the top and bottom quartiles of both groups were selected. Target gene expression was then analysed and represented as box-and-whisker plots. Statistical significance was assessed using Mann-Whitney tests with correction for multiple hypothesis testing.
METHODS
Cell lines. 368T1 and 482N1 cells were generated previously 6 . KPD F/-and -/sarcoma cells were a gift of P. A. Sharp 24 . Cancer Research UK Cell Services provided HEK293, Phoenix ampho, NCI-H1299 and SK-MES-1 cells. All cell lines were cultured in DMEM medium with 10% FBS, 10 mM glutamine and 1% penicillin and streptomycin at 37 uC in a 5% CO 2 -95% air incubator. Drug and reagent treatment. For Western blot analysis, luciferase, qRT-PCR and BrdU analysis, 368T1 cells were co-treated with 2 ng ml 21 TGF-b and either DMSO or 2.5 mM SB-431542 ('SB') and 482N1 cells were treated with either DMSO or 2.5 mM SB-431542 for 24 h. For soft-agar analysis, cells were fed with media containing either DMSO or SB. For Western blot analyses, 368T1 and 482N1 cells were plated (2.5 3 10 5 cells) into 6-well plates overnight. Cells were then treated with DMSO, 1 mM AZD6244 or 1 mM PIK-75 for 2 h and lysates were prepared. Lentivirus and retrovirus production. Short hairpin RNA (shRNA) lentiviruses (which are listed in Supplementary Table 1) were generated by co-transfection of HEK293 cells with shRNA vector and packaging vectors pCMV-VSVG and pCMV-8.2. MSCV-based retroviruses were generated by transfection of Phoenix ampho cells with retroviral vectors. Forty-two and seventy-two hours after transfection, virus particles in the medium were harvested, filtered and transduced onto cells. Generation of stable cell lines. Expression vectors were initially linearized overnight using BglII. Linearised DNA was then transfected into cells in 24-well plates, with media replaced 6 h later. Cells were then re-plated into 6-well plates in the presence of 500 mg ml 21 G418 for selection over 2 weeks. For lentiviral and retroviral infection, cells were infected in 6-well plates and subsequently split into 10-cm dishes in the presence of 2.5 mg ml 21 puromycin for selection over 72 h. Western blotting. Western blot analysis was performed using standard methods. Antibody details are provided in Supplementary Table 2 . qRT-PCR. RNA was isolated using RNA Bee according to the manufacturer's instructions (AMS Bio). Both standard and miRNA-specific qRT-PCR was performed using QuantiTect SYBR Green primers as per the manufacturer's instructions (QIAGEN). Primer details are provided in Supplementary Table 3 . Luciferase assays. For the CAGA12 reporter, cells were seeded into 96-well plates in triplicate and co-transfected with pRL-TK (Promega) and either control pGL3 or the TGF-b reporter pCAGA12-GL3 (ref. 22 ). Twenty-four hours later, luciferase activities were determined using the Dual-Luciferase Assay System as per the manufacturer's instructions (Promega).
For the Tgfbr3 39 UTR, cells were seeded into 96-well plates in triplicate and cotransfected with pGL3 (Promega) and either the control pRL-CXCR4 (ref. 30) , the wild-type or mutant fragment of the Tgfbr3 39 UTR. Luciferase activities were determined as above. BrdU analysis. Cells were plated in triplicate into 6-well plates overnight (2.5 3 10 5 cells per well). They were then treated with 10 mM BrdU for 1 h, trypsinized, washed in PBS and stained for BrdU and DAPI. Analysis was performed using standard methods by the Cancer Research UK Flow Cytometry Facility. siRNA and miRNA transfection. Cells were transfected with siRNA and miRNA as described previously 29 . Cells were subsequently plated into soft-agar assays as above or collected for RNA or protein as above. polyHEMA plating analysis. Six-well plates were either mock coated or coated with polyHEMA (polyhydroxyethylmethacrylate) for suspension growth as previously described 31 . Cells were subsequently plated into these 6-wells overnight and BrdU analysis was performed as described above. Histopathological analysis. After mice were euthanized by CO 2 asphyxiation, lungs were collected and fixed overnight in 10% formalin. They were subsequently placed in 70% ethanol and submitted for embedding, sectioning, and haematoxylin and eosin (H&E) staining. In vitro transcription. TOPO cloned fragments of Hmga2 and Tgfbr3 were in vitro transcribed using the SP6 MAXIscript kit as per manufacturers' instructions (Ambion). RNA was subsequently purified using the RNEasy cleanup kit as per manufacturers' instructios (Qiagen). Transcript copy-number analysis. To determine the transcript copy number, RNA was prepared from 2 3 10 6 482N1 cells using RNA Bee as described above. qRT-PCR was performed for Hmga2, Tgfbr3 and let-7a, let-7c, let-7e let-7f and let-7i as described above. Threshold cycle (C T ) values were compared to a twofold dilution series of either in-vitro-transcribed Hmga2 or Tgfbr3, or synthetic let-7a, let-7c, let-7e let-7f and let-7i miRNA mimics (Qiagen). Moles of transcript and copies of transcript per cell were then calculated using standard stoichiometric methods. Confidence intervals were calculated using a t-statistic under Student's t-test. RNA-library production and next-generation sequencing. Total RNA was generated from the 482N1 Hmga2 allelic series (with biological triplicates) as described above. The Total RNA samples were initially quality controlled using the 6000 Nano RNA Chip on the BioAnalyser 2100 (Agilent) to ensure RNA integrity and estimate concentration before starting the procedure. If the samples passed the initial quality control, the total RNA samples were subjected to poly-A selection using Sera-Mag oligo deoxy-thymine (dT) beads (Thermo Fisher Scientific), and the bound poly-A RNA species utilized for downstream library preparation using the Illumina mRNA kit RS-122-2101 (TruSeq Stranded mRNA Sample Prep, Illumina). The standard PCR cycles suggested in the protocol were also altered to match the concentration of the total RNA from the initial quality control. After production of the mRNA libraries a final quality control was performed on a DNA 1000 chip using the BioAnalyser 2100 (Agilent). If the mRNA libraries passed the quality control they were ready for flow-cell cluster formation on a cBot and then 100-bp paired-end sequencing by synthesis on the HiSeq 2500 was performed. RNA-seq data processing and analyses. We aligned 100-bp paired-end sequencing reads to the mouse genome (mm9, UCSC) using Tophat2/Bowtie2 (ref. 32) allowing for five mismatches, a mate-inner-distribution of 240 and a mate-standard-deviation of 50. These library fragment metrics were derived from an alignment of 5e5 sampled reads to the mouse transcriptome. We identified read-pair mappings to gene structures derived from RefSeq (RefGene table, UCSC) using the summarizeOverlaps function with mode IntersectStrict (GenomicRanges, Bioconductor). This generated a mean fragments per sample value of 33.5e6. Using these raw counts we identified genes expressed across the sample groups. We removed genes with a count #10 across all samples prior to statistical analysis. The differential analysis was carried out using edgeR 33 , applying TMM (trimmed Mean of M-values) library normalization and a 0.0005 false discovery rate (FDR) to select expressed transcripts. In addition, we calculated gene-level fragments per kilobase of exon per million fragments mapped (FPKM) values for the same gene set using Cufflinks 34 . Sylamer analysis. A list of Ensembl gene identifiers was generated from the set of transcripts expressed in the samples described above. This set of transcripts was then placed in rank order by their differential expression between two groups and analysed using the Sylamer algorithm via the SylArray platform 17 . A Sylamer plot was then generated for all 8mer miRNA strings whose target sites were enriched significantly (P , 0.001 by hypergeometric testing). Statistical testing. Unless otherwise specified, statistical significance was assessed by the Student's t-test. Vector cloning. For Hmga2: pCDNA3.1-Hmga2 WT and Hmga2 m7 ('WT' and 'm7') were acquired from Addgene (Plasmid nos 14789 and 14792) 13 . To generate pCDNA3.1-Hmga2 ATG WT and pCDNA3.1-Hmga2 ATG m7 ('ATG WT' and 'ATG m7'), the WT and m7 constructs were mutated by site-directed mutagenesis as per the manufacturer's instructions (Stratagene) using primers 59-GGTAG CGGCGGCGGGAGGCAGGCTGAGCGCACGCGGTGAGG-39 and 59-CCTC ACCGCGTGCGCTCAGCCTGCCTCCCGCCGCCGCTACC-39. To generate 482N1 shHmga2 stable cell lines, WT, m7, ATG WT and ATG m7, the shRNA-binding site was mutated using primers 59-CCATTTCTGCAAGCTAAGTATGTTTGC AGGAGCCCCGGCTCCGGACGCGTAACTGCATCCAACTTTCTCC-39 and 59-GGAGAAAGTTGGATGCAGTTACGCGTCCGGAGCCGGGGCTCCTGCAA ACATACTTAGCTTGCAGAAATGG-39.
For pRL-Tgfbr3: a fragment containing the Tgfbr3 39 UTR was PCR amplified from 482N1 cDNA using primers 59-TAAGAACTCGAGCTGCGTGTGTTCT CCGCAG-39 and 59-TAACAAGCGGCCGCCTGTCAGTTTAATGAACGAACC-39. Both the PCR product and pRL-CXCR4 were digested with XhoI and NotI and ligated together to generate pRL-Tgfbr3. The let-7 mutant was generated by sitedirected mutagenesis as above using primers 59-GCAGGCGCGTGCCTGTCT TTTTGTACTGTAACGGGCTCATGGTTTGAATGATGAGCGTACTGCTGG TTG-39 and 59-CAACCAGCAGTACGCTCATCATTCAAACCATGAGCCCG TTACAGTACAAAAAGACAGGCACGCGCCTGC-39.
For Hmga2-TOPO/Tgfbr3-TOPO: a fragment containing the Hmga2 cDNA sequence recognized by the respective qRT-PCR primers was PCR amplified from 482N1 cDNA using primers 59-CTACATCCCGTCTCCCGAAAGGTGCTGG-39 and 59-GGATCCGGTAGAAATTGAATGTCGGCGCCCCCTAATC-39. A fragment containing the Tgfbr3 cDNA sequence recognized by the respective qRT-PCR primers was PCR amplified from 482N1 cDNA using primers 59-CTCG AGCAGAAGAAGTGCAAGGGGGCGTGAATATCG-39 and 59-CCATGTTGA AGGTAGCATTTCCATCGAGCTGGTCCTGGAAG-39. PCR products were subsequently TOPO cloned as per the manufacturer's instructions (Invitrogen) and used as substrates for in vitro transcription.
For Hmga2 WT/m7 39 UTR: a fragment containing the Hmga2 39 UTR was PCR amplified from the Hmga2 WT or Hmga2 m7 pcDNA3.1 constructs used for transfection. Products were amplified using primers 59-GCAGAATTCGGGGC GCCGACATTCAATTTC-39 and 59-TAAGCGGCCGCGCCCACAGAGGCTG TTATGTTTATTG-39. PCR products were subsequently TOPO cloned as per the manufacturer's instructions (Invitrogen). TOPO clone inserts and pcDNA3.1-Hmga2 WT were EcoRI digested and ligated together to generate pcDNA3.1-Hmga2 WT 39 UTR and pcDNA3.1-Hmga2 m7 39 UTR. 
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Extended Data Figure 2 | Let-7 regulates Hmga2 ceRNA activity, which functions through the 39 UTR and controls Nkx2.1-mediated anchorageindependent growth. a, Lysates were prepared from the 368T1 Hmga2 WT and Hmga2 ATG WT; 482N1 shluc empty, shHmga2 WT and shHmga2 ATG WT cells reverse transfected with either control miRNA (miR-10a) or let-7e. Western blot analysis was subsequently performed for pSmad2, Smad2, Tgfbr3 and Rho. b, Cells were transfected as in a and soft-agar analysis was performed as in Fig. 1d . Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. c, 368T1 cells were transfected with empty vector, Hmga2 WT (as in Fig. 1b) , the wild-type 39 UTR of Hmga2 (WT 39 UTR) or the let-7-site-mutated 39 UTR (m7 39 UTR). Softagar analysis was performed as in Fig. 1d . Values are technical triplicates, have been performed independently twice, and represent mean 6 s.d. d, 482N1 cells were infected with empty retrovirus or a retrovirus overexpressing Nkx2.1. The Hmga2 allelic series was then introduced into Nkx2.1 cells (with just empty vector in the empty retrovirus cells) and soft-agar analysis was performed as in Fig. 1d . Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. ***P , 0.0005; **P , 0.005; *P , 0.05.
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Extended Data Figure 4 | Hmga2 ceRNA function specifically upregulates let-7 target transcripts. RNA-seq was performed for cells from the 482N1 Hmga2 allelic series. a, The set of transcripts expressed in shluc empty and shHmga2 empty cells were ranked in order of differential expression and Sylamer analysis was performed. Sylamer plots were then generated across the transcript set for all octomer miRNA strings statistically enriched (P , 0.001 by hypergeometric testing). The Sylamer plot for mmu.let-7a.8(A1) is delineated in red. b, The set of transcripts expressed in shHmga2 WT and shHmga2 empty cells were ranked in order and Sylamer analysis and plots were generated as in a. c, The set of transcripts expressed in shHmga2 ATG WT and shHmga2 empty cells were ranked in order and Sylamer analysis and plots were generated as in a. d, The set of transcripts expressed in shHmga2 m7 and shHmga2 empty cells were ranked in order and Sylamer analysis and plots were generated as in a. e, The set of transcripts expressed in shHmga2 ATG m7 and shHmga2 empty cells were ranked in order and Sylamer analysis and plots were generated as in a. f, Copies-per-cell analysis of Hmga2, Tgfbr3, and let-7 family members in 482N1 cells. Expression levels of transcripts in 482N1 cells were compared to a dilution series of in vitro transcribed mRNA (Hmga2 and Tgfbr3) or chemically synthesized microRNA (let-7a, let-7c, let-7e, let-7f and let-7i). Comparison of expression in 482N1 cells to the respective standard curves allowed calculation of copies per cell. Values are technical triplicates, have been performed independently three times, and represent mean with the 99% confidence interval. Confidence intervals were determined using a t-statistic.
Macmillan Publishers Limited. All rights reserved ©2014 Extended Data Figure 5 | Hmga2 regulates target transcripts through both protein and ceRNA function to promote TGF-b signalling. a, Effect of Hmga2 depletion on potential Hmga2 target genes from Supplementary Table  5 . RNA was purified from 482N1 shluc and shHmga2 cells and qRT-PCR was performed for Gapdh and the overlapping set of transcripts upregulated in metastasis-generating lung cancer cells (T met ) and predicted let-7 target transcripts described in Supplementary Table 5 . Values are normalized to shluc. Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. b, Effect of re-expression of either Hmga2 WT or ATG WT on target transcripts in knockdown cells. RNA was purified from 482N1 shluc empty, shHmga2 empty, shHmga2 WT and shHmga2 ATG WT cells and qRT-PCR was performed for Gapdh and the Hmga2 regulated transcripts from a. Values are normalized to shluc empty. Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. c, Induction of target transcripts by let-7 loss-of-function. RNA was purified from 482N1 shHmga2 cells expressing tough decoys targeting miR-122 or let-7 and qRT-PCR was performed on the transcripts from a. Values are normalized to the miR-122 tough decoy. Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. d, Suppression of target transcripts by let-7 overexpression. RNA was purified from 482N1 cells transfected with either miR-10a or with let-7e and qRT-PCR was performed on the transcripts from a. Values are normalized to the miR-10a expressing cells. Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. e, Hmga2 WT and ATG WT specifically induce expression of a TGF-b luciferase reporter (CAGA12) but not a control luciferase reporter (GL3) in both 368T1 and 482N1 cells. Values are normalized to co-transfected pRL-CXCR4 plasmid 30 . 368T1 values are normalized to empty and 482N1 values are normalized to shluc empty. Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. with propagated error. f, RNA was purified from 368T1 and 482N1 cells expressing the Hmga2 allelic series as in Fig. 1c signalling and anchorage-independent growth without affecting general proliferation. a, Tgfbr3 depletion reduces TGF-b reporter activity in 368T1 WT and ATG WT and 482N1 cells. Cells were infected with the listed shRNAs and transfected with either GL3 or CAGA12 luciferase reporters as in Extended Data Fig. 5e . Values are normalized to co-transfected pRL-CXCR4 plasmid. Values are normalized to shluc. Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. with propagated error. b, Tgfbr3 knockdown suppresses TGF-b target gene expression. RNA was purified from 368T1 WT and ATG WT and 482N1 cells expressing the listed shRNAs and qRT-PCR was performed for various TGF-b target genes as in Extended Data Fig. 5f . Values are normalized to Gapdh and shluc. Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. c, Tgfbr3 knockdown does not generally affect proliferation. Cells were infected with the listed shRNAs and BrdU analysis was performed as in Extended Data Fig. 3a . Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d (n 5 3). d, 482N1 cells were transfected with a scrambled siRNA (siscr) or siRNAs targeting Hmga2, Angptl2, Col1a2, Fndc3, Hmga1, Skil or Tgfbr3. RNA was purified and qRT-PCR was performed for Gapdh and the relevant target transcripts. Values are normalized to both Gapdh and specific transcript expression in siscr cells. Values are technical triplicates, have been performed independently twice, and represent mean 6 standard deviation (s.d.) with propagated error. e, 482N1 cells transfected with the siRNAs described in d and were plated in soft agar, and the number of colonies was analysed as in Fig. 1d . Values are technical triplicates, have been performed independently twice, and represent mean 6 s.d. ***P , 0.0005; **P , 0.005; *P , 0.05.
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Extended Data Figure 9 | Inhibition of TGF-b signalling suppresses Hmga2 ceRNA-driven lung cancer cell transformation without altering general proliferation. a, SB-431542 ('SB') suppresses TGF-b pathway activation. 368T1 cells were treated with or without TGF-b 6 SB, and 482N1 cells were treated with or without SB. Twenty-four hours later, lysates were prepared and Western blot analysis was performed for pSmad2 and total Smad2. b, SB suppresses TGF-b reporter activity. 368T1 WT and ATG WT and 482N1 cells were treated with or without SB for 24 hours and transfected with either GL3 or CAGA12 luciferase reporters as in Extended Data Fig. 5e . Values are normalized to co-transfected pRL-CXCR4 plasmid. Values are normalized to vehicle treatment (2SB). Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. with propagated error. c, SB suppresses TGF-b target gene expression. 368T1 WT and ATG WT and 482N1 cells were treated with or without SB for 24 hours. RNA was purified and qRT-PCR was performed for various TGF-b target genes as in Extended Data Fig. 5f . Values are normalized to Gapdh and to vehicle treatment (2SB). Values are technical triplicates, have been performed independently three times, and represent mean 6 standard deviation (s.d.) with propagated error. d, SB suppresses anchorage-independent growth driven by Hmga2 ceRNA activity. 368T1 WT and ATG WT and 482N1 cells were plated for soft-agar colony growth in the continual absence or presence of SB. Soft-agar colony analysis was performed as in Fig. 1d . Values are technical triplicates, have been performed independently three times, and represent mean 6 s.d. e, SB does not generally affect proliferation. 368T1 WT and ATG WT and 482N1 cells were treated with or without SB for 24 hours and BrdU analysis was performed as in Extended Data Fig. 3a . Values are technical triplicates, have been performed independently three times, mean 6 s.d (n 5 3). f, SB treatment suppresses multiple Hmga2 ceRNA target genes. 482N1 cells were treated with or without SB for 24 hours. RNA was purified and qRT-PCR was performed for Hmga2 and Hmga2 ceRNA targets. Values are normalized to vehicle treatment (2SB). Values are technical triplicates, have been performed independently twice, and represent mean 6 standard deviation (s.d.) with propagated error. g, TGF-b treatment induces multiple Hmga2 ceRNA target genes. 368T1 cells were treated with vehicle (DMSO) or TGF-b for 24 hours. RNA was purified and qRT-PCR was performed for Hmga2 and Hmga2 ceRNA targets. Values are normalized to Gapdh and vehicle treatment (DMSO). Values are technical triplicates, have been performed independently twice, and represent mean 6 standard deviation (s.d.) with propagated error. ***P , 0.0005; **P , 0.005; *P , 0.05.
In this Letter, we reported that Hmga2 promotes lung cancer progression in mouse and human cells by operating as a competing endogenous RNA for the let-7 microRNA family. It has been brought to our attention that the cell lines used in the RNA sequencing (RNAseq) experiment presented in Extended Data Fig. 4 of the Letter cannot be those specified in the figure legend. Moreover, these data cannot generate the Sylamer plots presented in this figure. The cell line substitution also casts doubt on which cells were used for experiments presented elsewhere in the paper. Although replication of other experiments in the Letter have not uncovered any further inconsistencies, given this uncertainty and the clear issues with Extended Data Fig. 4 , we think it prudent to retract the paper pending more thorough investigation. We apologize for any adverse consequences that this may have caused.
